Skip to main content
Science|Business

Bringing together industry, research and policy

Menu
  • News
    • Funding Newswire
    • R&D Express
    • R&D Policy
    • Health
    • Energy
    • Climate
    • Digital
    • Defence
  • Funding Newswire
    • Why subscribe?
  • Reports
  • Events
  • The Network
    • Why Join?
    • Become a member
    • S|B Integrators
    • Network Updates
  • Communications Services
    • Overview
    • Campaigns
    • Events
    • EU Projects
    • Enquire today
  • About Us
    • Contact
    • Team
    • Privacy
    • Careers
  • All
  • R&D Policy
    • Technology transfer
    • Horizon Europe
    • Start-ups
    • International news
    • EU budget
    • Brexit
    • European Research Council
    • Universities
    • Research and innovation gap
    • Planning FP10
    • FP10
    • European Institute of Innovation and Technology
    • Intellectual property
    • Patents
    • European Innovation Council
    • European Research Area
    • Industry
    • Partnerships
    • Research infrastructures
    • SMEs
    • Open science
    • Sovereignty
    • Careers
    • Missions
    • Cohesion policy
    • Basic science
    • Erasmus
    • Assessment
    • Synergies
  • R&D Funding
  • Health
    • Vaccines
    • Life sciences
    • Drug development
    • COVID-19
    • Biotech
    • Clinical trials
    • Antimicrobial resistance
    • Medical technology
  • Energy
    • Hydrogen
    • Renewables
    • Nuclear fusion
    • Batteries
    • Mobility
  • Digital
    • ICT
    • AI
    • Quantum computing
    • Semiconductors
    • Data
    • Super computers
    • Robotics
  • Climate
    • Green technology
    • Low-carbon
    • Agrifood
    • Circular economy
    • Biodiversity
    • Oceans
  • Defence
    • Dual use
    • Aerospace
    • European Defence Fund
    • Cybersecurity
    • European Space Agency
  • By Table.Media

Advertising
New antibiotics won’t stop antimicrobial resistance. Luckily, there are other things we can try

New antibiotics won’t stop antimicrobial resistance. Luckily, there are other things we can try

Vaccines could offer hope - but who to vaccinate, and against what, has no clear answer yet. Read IMI Executive Director Dr Pierre Meulien’s perspective on what is needed to tackle antimicrobial resistance.

18 Nov 2019
More news about
IMI
Advertising
ADVANCE: Towards a pan-European vaccination monitoring system

ADVANCE: Towards a pan-European vaccination monitoring system

Vaccines are an effective public health measure, yet public distrust in immunisation is resulting in outbreaks of preventable diseases. IMI’s ADVANCE project worked to create an open system for monitoring vaccine coverage, benefits and risks in Europe.

13 May 2019
More news about IMI
Call for public investment to reverse Europe’s rising tide of vaccine scepticism

Call for public investment to reverse Europe’s rising tide of vaccine scepticism

Experts decry record-breaking scepticism towards vaccines across the EU and plead with member states to monitor attitudes and work to build public confidence

25 Jul 2017
News

Senior EU research official to join Merck & Co.

Ruxandra Draghia-Akli, deputy director general for research, in surprise move to US pharma group in June

04 May 2017
News

PATH Malaria Vaccine Initiative brings GlaxoSmithKline and Dutch biotech Crucell into collaboration

The partners will work on the development of a second-generation malaria vaccine, combining two existing vaccines to improve immune responses
07 Jun 2011
News

BigDNA to fund academic research on phage vaccine at Strathclyde University

25 Nov 2010
News

Okairos raises €16M for T-cell vaccine development

15 Sep 2010
News

Cytos lands Singaporean partner for flu research

21 Jul 2010
News

Mucosis granted €3M innovation credit line

02 Jun 2010
News

IASMA: New method for identifying oil from sharks

19 May 2010
News

Pagination

  • Previous page ‹‹
  • You're on Page 5
  • Next page ››

Get the Science|Business newsletters

newsletter iconReceive the Funding Newswire [full access requires a subscription] each Tuesday, our Policy Bulletin each Thursday, and the fortnightly R&D Express, tracking reforms and investments in central and eastern Europe. 

  Click and choose your publications

Funding Newswire subscription

align-right

Follow where the public and private R&I money is going and which collaborative opportunities you can pursue. 

Subscribe today

Log in

Find out more about the Science|Business Network

Network iconA unique international forum for public research organisations and companies to connect their external engagement with strategic interests around their R&D system.

  Why join?

  Become a member

Jobs

The International Federation of Library Associations is looking for a KR21 Brussels Consultant (part-time)
FY2026 Call for RIKEN ECL Team/Unit Leaders
Extended deadline: Call for applications for the position of Director General of the HUN-REN Wigner Research Centre for Physics (HUN-REN Wigner RCP)
Extended deadline: Call for applications for the position of Director General of the HUN-REN Institute for Nuclear Research (HUN-REN ATOMKI)
Extended deadline: Call for applications for the position of Director General of the HUN-REN Institute for Earth Physics and Space Science (HUN-REN EPSS)
Extended deadline: Call for applications for the Director General position at the HUN-REN Biological Research Centre (BRC)
Home

Privacy   |   T&Cs   |   © 2026 Science Business Publishing Ltd.

  • News
    • Funding Newswire
    • R&D Express
    • R&D Policy
    • Health
    • Energy
    • Climate
    • Digital
    • Defence
  • Funding Newswire
    • Why subscribe?
  • Reports
  • Events
  • The Network
    • Why Join?
    • Become a member
    • S|B Integrators
    • Network Updates
  • Communications Services
    • Overview
    • Campaigns
    • Events
    • EU Projects
    • Enquire today
  • About Us
    • Contact
    • Team
    • Privacy
    • Careers